{"gene":"KITLG","run_date":"2026-06-10T02:59:49","timeline":{"discoveries":[{"year":1993,"finding":"FSH and its intracellular mediator cAMP increase mRNA levels for Steel factor (SLF/KITLG) — both the soluble and transmembrane isoforms — in cultured mouse Sertoli cells. Soluble recombinant SLF selectively stimulates DNA synthesis in type A spermatogonia in a dose-dependent manner, independent of serum.","method":"Primary Sertoli cell culture with FSH/cAMP treatment, PCR for isoform-specific mRNA detection, [3H]-thymidine incorporation assay in isolated spermatogonial populations, autoradiography","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional assay (DNA synthesis) with defined ligand, isoform-specific PCR, single lab but multiple orthogonal methods","pmids":["7677988"],"is_preprint":false},{"year":1992,"finding":"SCF (KITLG) is the major migration, survival, proliferation, and maturation factor for mast cell precursors acting through the c-Kit tyrosine kinase receptor. W/Wv mice lacking functional c-Kit virtually lack tissue mast cells, establishing that the KITLG/c-Kit axis is essential for mast cell development in vivo.","method":"Genetic mouse models (W/Wv loss-of-function), adoptive transfer / mast cell reconstitution experiments in multiple tissues","journal":"Annals of the New York Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with defined loss-of-function phenotype replicated across tissues; foundational work replicated across multiple labs","pmids":["1280935"],"is_preprint":false},{"year":1993,"finding":"Membrane-bound SLF (KITLG transmembrane isoform) — but not soluble SLF — can support sustained proliferation of FDC-P1 myeloid cells expressing c-Kit on fibroblast co-culture. The Sl/Sld mutant fibroblasts producing only soluble SLF fail to support these cells, demonstrating a functional distinction between membrane-bound and soluble KITLG isoforms. GM-CSF and IL-3 downregulate surface c-Kit expression in a unidirectional manner, reducing responsiveness to SLF.","method":"Fibroblast co-culture with neutralizing antibodies against GM-CSF, Sl/Sld mutant fibroblasts (soluble SLF only), cell adaptation assay, c-kit mRNA quantification, surface c-Kit protein measurement","journal":"Experimental hematology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal genetic/cell biological comparison of isoforms, single lab with multiple orthogonal approaches","pmids":["7684700"],"is_preprint":false},{"year":2002,"finding":"Gab2 adaptor protein is required for KitL/c-Kit signaling and mast cell development. In Gab2-deficient mice, mast cell numbers are markedly reduced, and bone marrow-derived mast cells grow poorly in response to KITLG. KITLG-induced ERK MAP kinase and Akt activation are both impaired in Gab2-deficient cells, placing Gab2 downstream of c-Kit in the KITLG signaling cascade.","method":"Gab2 knockout mice, bone marrow-derived mast cell culture with KitL, flow cytometry for mast cell numbers, ERK and Akt phosphorylation assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic KO with defined cellular phenotype plus defined downstream signaling readouts (ERK, Akt), reciprocal functional evidence","pmids":["11861309"],"is_preprint":false},{"year":2001,"finding":"KITLG (SCF) and its receptor c-Kit control multiple stages of melanocyte migration and survival during mouse ontogeny. Spatiotemporally specific expression of SCF in the dermis is required for c-Kit-dependent melanocyte colonization; SCF transgene expression rescues specific stages of melanocyte development, and functional c-Kit blockade by monoclonal antibody identifies distinct c-Kit-dependent and c-Kit-independent developmental stages.","method":"SCF transgenic mice, anti-c-Kit monoclonal antibody functional blockade, white spotting mutant (Sl/W) mouse analysis, immunohistochemistry","journal":"The journal of investigative dermatology. Symposium proceedings","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgenic rescue and antibody blockade in vivo, single lab, multiple genetic approaches","pmids":["11764276"],"is_preprint":false},{"year":2002,"finding":"Seven ENU-induced point mutations in Kitl (KITLG) at the Steel locus were characterized; five are missense mutations each affecting residues within or near conserved alpha-helical domains of KITLG. This establishes that the helical domain residues are structurally required for KITLG function, as homozygous mutations cause severe anemia and lethality correlated with mutation severity.","method":"ENU mutagenesis screen, DNA sequencing of Kitl alleles, phenotypic analysis of peripheral blood and pigmentation in heterozygous and homozygous mice","journal":"Genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — allelic series with in vivo phenotype correlation to mutation site, single lab","pmids":["12242244","12242245"],"is_preprint":false},{"year":2002,"finding":"SCF (KITLG) synergizes with G-CSF to promote expansion of primitive hematopoietic cells and peripheral blood progenitor cell mobilization. This synergy involves downregulation of p27Kip1 and independent phosphorylation of STAT3 on both tyrosine and serine residues as key intracellular biochemical events.","method":"MO7e-G cell system recapitulating SCF/G-CSF synergy, Western blot for p27Kip1, STAT3 phosphorylation (tyrosine and serine) analysis","journal":"Leukemia & lymphoma","confidence":"Low","confidence_rationale":"Tier 3 / Weak — mechanistic findings reported in a review/summary paper with limited methodological detail; single cell system","pmids":["12152985"],"is_preprint":false},{"year":2004,"finding":"Intracellular trafficking of KITLG (Kit ligand) to the cell surface is controlled at the level of the endoplasmic reticulum (ER) by a C-terminal valine residue in the cytoplasmic tail, positioned 19–36 amino acids from the transmembrane/cytoplasmic domain border. This valine functions as a specific ER export signal mediating recruitment of KITLG into COPII-coated ER exit sites and ER-to-Golgi vesicular transport. Deletion or substitution of this valine causes ER accumulation and reduced cell surface transport.","method":"Deletion/substitution mutagenesis of Kitl cytoplasmic tail, GFP-VSV-G fusion construct live imaging, COPII colocalization, cell surface biotinylation/transport assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis combined with live cell imaging and COPII colocalization; multiple orthogonal methods in single study establishing specific ER export signal","pmids":["15475566"],"is_preprint":false},{"year":2007,"finding":"KITLG (SCF) binding to c-Kit induces rapid and complete receptor dimerization, leading to activation by autophosphorylation of the catalytic tyrosine kinase domain. This generates signal transduction regulating cell growth through multiple pathways including PI3K, Src, JAK/STAT, PLC-γ, and MAPK. Gain-of-function mutations in the inhibitory juxtamembrane domain (exon 11) of c-Kit constitutively activate signaling independent of KITLG.","method":"Review integrating biochemical assays of c-Kit dimerization, autophosphorylation, and downstream pathway activation; mutational analysis of juxtamembrane domain","journal":"Gene","confidence":"Low","confidence_rationale":"Tier 3 / Weak — review article summarizing prior experimental findings without primary new data; well-established mechanism but not directly experimentally established in this paper","pmids":["17659849"],"is_preprint":false},{"year":2008,"finding":"Tumor-derived KITLG (SCF) mediates mast cell chemotactic migration (at low concentrations) and activation (at higher concentrations) via c-Kit receptor on mast cells. Activated mast cells upregulate NF-κB and AP-1 activity in tumor cells, increase IL-17 expression, release adenosine, and expand T regulatory cells, thereby promoting immunosuppression. This establishes KITLG as the initiating signal for tumor microenvironment remodeling by mast cells.","method":"In vitro mast cell chemotaxis assays with recombinant SCF, cytokine measurement, NF-κB/AP-1 reporter assays, T cell suppression assays, flow cytometry","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional assays with defined ligand concentrations, single lab, several orthogonal readouts","pmids":["18524989"],"is_preprint":false},{"year":2008,"finding":"KITLG (KIT ligand/KITL) attenuates 4-vinylcyclohexene diepoxide (VCD)-induced primordial and primary follicle loss in rat ovaries. VCD decreases Kit expression and increases Kitl mRNA and protein, suggesting compensatory upregulation. Addition of exogenous KITL to ovarian cultures during VCD exposure rescues follicle loss, establishing that KIT/KITL signaling is critical for follicular survival.","method":"In vivo VCD dosing and in vitro ovarian culture, microarray analysis, qPCR, Western blot, growth factor rescue experiments in primary ovarian cultures","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — rescue experiment with defined ligand, in vivo and in vitro concordant results, single lab","pmids":["18448842"],"is_preprint":false},{"year":2009,"finding":"SCF (KITLG) inhibits IGF-I-mediated proliferation in isolated growth plate chondrocytes by attenuating ERK1/2 activation, and promotes chondrocyte differentiation in ATDC5 cells. KITLG signals through its receptor KIT to modulate the pace of differentiation at the growth plate.","method":"Chondrocyte isolation and culture, proliferation assays, ERK1/2 phosphorylation Western blot, ATDC5 differentiation assay with collagen X/II/aggrecan markers","journal":"Molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct functional assay with recombinant ligand, defined signaling readout (ERK1/2), multiple cell systems","pmids":["19897599"],"is_preprint":false},{"year":2011,"finding":"Mutations in KITLG cause familial progressive hyper- and hypopigmentation (FPHH). Three missense mutations (including p.Val33Ala and p.Thr34Pro) located in a conserved β-strand of KITLG co-segregate with disease, suggesting this structural region is important for activation of the c-Kit receptor. The same gene harbors mutations causing familial progressive hyperpigmentation (FPH) and likely DUH2, establishing KITLG as an important modulator of skin pigmentation.","method":"Genome-wide linkage analysis, mutation screening, co-segregation analysis in seven families","journal":"The Journal of investigative dermatology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — genetic co-segregation without direct functional validation of mutation mechanism in this paper","pmids":["21368769"],"is_preprint":false},{"year":2015,"finding":"Mutations in KITLG cause non-syndromic unilateral/asymmetric hearing loss and Waardenburg syndrome type 2. In vitro studies showed that the p.His67_Cys68delinsArg transmembrane isoform of KITLG is not detectable at the cell membrane, supporting loss-of-function pathogenicity. The p.Leu104Val mutation associated with WS2 produces a transmembrane KITLG that localizes to the cell membrane but yields reduced secreted soluble KITLG, suggesting a dominant-negative or gain-of-function effect via impaired shedding.","method":"Cell surface localization assay (immunofluorescence/flow cytometry), ELISA for soluble KITLG in conditioned medium, transfection of mutant constructs","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct in vitro functional studies of mutant protein localization and secretion, multiple isoforms tested, single lab","pmids":["26522471"],"is_preprint":false},{"year":2015,"finding":"HIF-1α directly binds to the hypoxia response element (HRE) region of the KITLG promoter under hypoxic conditions, activating KITLG transcription in pancreatic ductal adenocarcinoma cells. KITLG knockdown under hypoxia reduces cell proliferation and invasion, and exogenous SCF (KITLG) rescues these defects after HIF-1α knockdown, placing KITLG downstream of HIF-1α in promoting PDAC progression.","method":"Chromatin immunoprecipitation (ChIP) assay, luciferase reporter assay, RNAi knockdown, Western blot, colony formation and Transwell invasion assays, in vivo xenograft with digoxin (HIF-1α inhibitor)","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — ChIP and luciferase assay establish direct transcriptional regulation; functional rescue supports pathway placement; single lab","pmids":["25799412"],"is_preprint":false},{"year":2015,"finding":"KITL (Kit ligand) supports retinoic acid-induced spermatogonial differentiation in a soma-free culture system. KITL activates an alternative pathway downstream of retinoic acid that is distinct from NRG1/ERBB2/ERBB3 signaling — ERBB2 inhibitors do not block KITL-dependent spermatogonial development, and KITL prevents degeneration of ERBB3-deficient spermatogonia upon differentiation.","method":"Soma-free spermatogonial culture with defined factors, ERBB2 inhibitor treatment, ERBB3-deficient cells, retinoic acid treatment, morphological and marker assessment of differentiation","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic (ERBB3-deficient) and pharmacological (ERBB2 inhibitor) dissection of pathway; soma-free system isolates germline-intrinsic signaling","pmids":["26500786"],"is_preprint":false},{"year":2017,"finding":"MAPK3/1 (ERK1/2) participates in primordial follicle activation through a mTORC1-KITL signaling axis in pre-granulosa cells. MAPK3/1 inhibition with U0126 reduces follicle activation, decreases phosphorylation of Tsc2, S6K1, and rpS6, and reduces KITL expression. The reduction in KITL leads to decreased Akt phosphorylation in oocytes and impaired Foxo3 nuclear export, linking MAPK3/1 upstream of mTORC1-KITL signaling.","method":"Ex vivo neonatal ovary culture with U0126 (MAPK3/1 inhibitor) and bpV(HOpic) (PTEN inhibitor), Western blot, immunofluorescence, follicle counting","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibition with multiple downstream readouts establishing pathway order; single lab, two experimental models","pmids":["28218391"],"is_preprint":false},{"year":2019,"finding":"SCF (KITLG)/cKIT signaling induces pathological ocular neovascularization mechanistically through phosphorylation of glycogen synthase kinase-3β (GSK-3β), enhancement of β-catenin nuclear translocation, and transcription of β-catenin target genes related to angiogenesis. Hypoxia upregulates cKIT expression in endothelial cells, enhancing their angiogenic response to SCF. In vivo, anti-SCF neutralizing IgG and cKit mutant mice show substantially suppressed pathological ocular neovascularization.","method":"cKit mutant mice, anti-SCF neutralizing antibody, β-catenin chemical inhibitors, Western blot for GSK-3β phosphorylation and β-catenin, oxygen-induced retinopathy and laser-induced CNV models, β-catenin agonist rescue experiment","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic and pharmacological loss-of-function with defined biochemical mechanism (GSK-3β/β-catenin), in vitro and in vivo concordant results, rescue experiment","pmids":["31434494"],"is_preprint":false},{"year":2023,"finding":"Gαi1 and Gαi3 associate with SCF (KITLG)-activated c-Kit in endothelial cells, promote c-Kit endocytosis and binding of key adaptor proteins, and are required for downstream SCF/c-Kit signal transduction. SCF-induced Akt-mTOR and ERK activation is robustly attenuated by Gαi1/3 silencing or dominant-negative mutations, and SCF-induced HUVEC proliferation, migration, and capillary tube formation are suppressed. In vivo endothelial knockdown of Gαi1/3 reduces SCF-induced retinal angiogenesis.","method":"Co-immunoprecipitation of Gαi1/3 with c-Kit, Gαi1/3 siRNA/KO/dominant-negative/overexpression, Akt and ERK phosphorylation Western blots, HUVEC functional assays, intravitreous AAV-shRNA injection in mice, streptozotocin diabetic retinopathy model","journal":"International journal of biological sciences","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP establishing physical interaction, multiple loss/gain-of-function approaches with defined signaling and functional readouts, in vitro and in vivo concordance","pmids":["37063428"],"is_preprint":false},{"year":2017,"finding":"Cadmium (Cd) exposure alters the kitl1/kitl2 mRNA ratio through changes in alternative splicing of kitl pre-mRNA in murine ovarian granulosa cells, associated with altered expression of 29 miRNAs. miRNAs including mmu-miR-27a-3p, mmu-miR-34b-5p, mmu-miR-297a-3p, mmu-miR-129-5p, and mmu-miR-107-3p show expression changes consistent with a regulatory role in kitl alternative splicing.","method":"In vitro granulosa cell Cd exposure, isoform-specific RT-PCR, miRNA microarray, bioinformatics pathway analysis, qPCR validation of miRNAs","journal":"Journal of applied toxicology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — associative miRNA-splicing correlation without direct functional validation of miRNA effects on splicing; single lab","pmids":["28892167"],"is_preprint":false},{"year":2019,"finding":"miR-27a directly targets the 3'UTR of KITLG mRNA, negatively regulating KITLG mRNA and protein expression. Overexpression of miR-27a in HEK-293T cells reduces KITLG expression, and dual-luciferase reporter assays confirm direct miR-27a binding to the KITLG 3'UTR. In goat skin, miR-27a expression is higher in white vs. brown animals and inversely correlates with KITLG expression.","method":"Luciferase 3'UTR reporter assay, miR-27a overexpression in HEK-293T cells, Western blot and qRT-PCR in goat skin, in vivo/in vitro concordance","journal":"Animal biotechnology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct 3'UTR luciferase validation confirms miR-27a targets KITLG; in vivo correlation supports finding; single lab","pmids":["31613171"],"is_preprint":false},{"year":2015,"finding":"miR-34c directly targets KITLG mRNA, and resveratrol upregulates miR-34c to suppress KITLG expression in colorectal cancer cells. Lentiviral knockdown of miR-34c rescues KITLG and partially reverses the anti-cancer effects of resveratrol, while miR-34c overexpression reduces KITLG. The anti-CRC effect of resveratrol is partially mediated through the miR-34c-KITLG axis, confirmed in xenograft models.","method":"Lentiviral miR-34c overexpression/inhibitor, Western blot and qPCR for KITLG, xenograft mouse model, methylation-specific PCR for miR-34c promoter","journal":"BMC cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss/gain-of-function of miR-34c with KITLG readout, in vitro and in vivo concordance, single lab","pmids":["26674205"],"is_preprint":false}],"current_model":"KITLG (Kit ligand/stem cell factor) is a dimeric growth factor produced in both membrane-bound and soluble isoforms whose cell surface transport is governed by a C-terminal valine ER export signal that recruits KITLG into COPII-coated vesicles; upon binding the c-Kit receptor tyrosine kinase, KITLG induces receptor dimerization and autophosphorylation, activating downstream cascades including PI3K/Akt, ERK/MAPK, JAK/STAT, and PLC-γ, with Gαi1/3 proteins serving as required intermediaries for c-Kit endocytosis and signal transduction; in hematopoietic and reproductive tissues, KITLG acts through the adaptor Gab2 to activate ERK and Akt for mast cell development, drives spermatogonial DNA synthesis and differentiation through KIT signaling downstream of FSH/cAMP in Sertoli cells and retinoic acid in the germline, regulates primordial follicle activation through a MAPK3/1→mTORC1→KITL→KIT/PI3K axis in granulosa and oocyte compartments, controls melanocyte migration and survival through spatiotemporally specific ligand expression, and promotes ocular neovascularization via GSK-3β phosphorylation and β-catenin nuclear translocation; KITLG expression is transcriptionally activated by HIF-1α binding to its promoter HRE under hypoxia, and post-transcriptionally repressed by miR-34c and miR-27a targeting its 3'UTR, while loss-of-function mutations in conserved helical or β-strand domains cause pigmentation disorders, hearing loss, and Waardenburg syndrome."},"narrative":{"mechanistic_narrative":"KITLG (Kit ligand/Steel factor/SCF) is a dimeric growth factor that signals through the c-Kit receptor tyrosine kinase to control survival, proliferation, migration, and differentiation across hematopoietic, reproductive, pigmentary, and vascular lineages [PMID:1280935, PMID:17659849]. Ligand binding induces c-Kit dimerization and autophosphorylation, engaging downstream PI3K/Akt, MAPK/ERK, JAK/STAT, Src, and PLC-γ cascades [PMID:17659849]; in mast cells these outputs require the adaptor Gab2, whose loss impairs KITLG-induced ERK and Akt activation and markedly reduces mast cell numbers in vivo [PMID:11861309], while Gαi1/Gαi3 associate with activated c-Kit to drive receptor endocytosis and are required for SCF-induced Akt-mTOR and ERK signaling in endothelial cells [PMID:37063428]. KITLG exists as membrane-bound and soluble isoforms with distinct activities, and its delivery to the cell surface depends on a C-terminal valine ER export signal that recruits it into COPII-coated ER exit sites [PMID:15475566, PMID:7684700]. KITLG governs lineage-specific developmental programs: it drives FSH/cAMP-stimulated DNA synthesis and retinoic-acid-coupled differentiation in the spermatogonial lineage [PMID:7677988, PMID:26500786], supports ovarian follicle survival and primordial follicle activation downstream of a MAPK3/1→mTORC1→KITL axis [PMID:18448842, PMID:28218391], and controls spatiotemporal melanocyte migration and survival [PMID:11764276]. In disease contexts, KITLG transcription is activated by HIF-1α binding to a promoter hypoxia response element to promote pancreatic tumor progression [PMID:25799412], and SCF/c-Kit signaling drives pathological ocular neovascularization through GSK-3β phosphorylation and β-catenin nuclear translocation [PMID:31434494]; KITLG message is post-transcriptionally repressed by miR-27a and miR-34c via its 3'UTR [PMID:31613171, PMID:26674205]. Loss-of-function or trafficking-defective KITLG mutations cause pigmentation disorders, hearing loss, and Waardenburg syndrome type 2 [PMID:26522471].","teleology":[{"year":1992,"claim":"Established that the KITLG/c-Kit axis is the essential, non-redundant determinant of a defined cell lineage in vivo, anchoring KITLG as a developmental growth factor rather than a modulatory one.","evidence":"Genetic W/Wv c-Kit loss-of-function mice with mast cell reconstitution across tissues","pmids":["1280935"],"confidence":"High","gaps":["Does not resolve which downstream signaling branches mediate each mast cell behavior","Phenotype assessed via receptor loss, not direct ligand manipulation"]},{"year":1993,"claim":"Defined how KITLG expression is hormonally controlled and showed soluble ligand alone drives a specific proliferative response, establishing a tissue context (testis) for KITLG action.","evidence":"Sertoli cell culture with FSH/cAMP, isoform-specific PCR, and [3H]-thymidine incorporation in type A spermatogonia","pmids":["7677988"],"confidence":"Medium","gaps":["Downstream c-Kit signaling pathway in spermatogonia not dissected","Relative roles of soluble vs membrane isoform in vivo unresolved"]},{"year":1993,"claim":"Demonstrated functional non-equivalence of the membrane-bound and soluble KITLG isoforms, showing that membrane presentation can be required to sustain c-Kit-dependent proliferation.","evidence":"FDC-P1/c-Kit fibroblast co-culture using Sl/Sld mutant fibroblasts producing only soluble SLF","pmids":["7684700"],"confidence":"Medium","gaps":["Structural basis for differential isoform activity not defined","Mechanism of GM-CSF/IL-3-induced c-Kit downregulation unexplained"]},{"year":2001,"claim":"Showed that spatiotemporally restricted KITLG expression patterns the migration and survival of a developing lineage, distinguishing c-Kit-dependent from c-Kit-independent stages.","evidence":"SCF transgenic mice, anti-c-Kit antibody blockade, and Sl/W mutant analysis of melanocyte development","pmids":["11764276"],"confidence":"Medium","gaps":["Molecular signaling controlling each developmental stage not mapped","Source cells of KITLG at each stage not fully defined"]},{"year":2002,"claim":"Placed an intracellular adaptor (Gab2) downstream of c-Kit, identifying a required node converting receptor activation into the ERK and Akt outputs needed for mast cell development.","evidence":"Gab2 knockout mice and bone marrow-derived mast cell culture with phospho-ERK/Akt readouts","pmids":["11861309"],"confidence":"High","gaps":["How Gab2 is recruited to c-Kit not defined","Whether Gab2 dependence generalizes to other KITLG-responsive lineages unknown"]},{"year":2002,"claim":"Linked KITLG to cooperative cytokine signaling and specific cell-cycle/transcriptional effectors in primitive hematopoietic cell expansion.","evidence":"MO7e-G synergy system with p27Kip1 and STAT3 phosphorylation Westerns (review/summary paper)","pmids":["12152985"],"confidence":"Low","gaps":["Reported in a summary paper with limited methodological detail","Direct causal link between STAT3/p27 changes and expansion not demonstrated"]},{"year":2002,"claim":"Mapped functional KITLG residues onto conserved alpha-helical domains, providing the first structure-function correlation for the ligand.","evidence":"ENU mutagenesis allelic series at the Steel locus with phenotype-severity correlation","pmids":["12242244","12242245"],"confidence":"Medium","gaps":["Biochemical effect of each missense mutation on c-Kit binding not measured","No high-resolution structure to interpret residue roles"]},{"year":2004,"claim":"Identified the molecular determinant controlling KITLG surface delivery, showing a C-terminal valine acts as an ER export signal recruiting KITLG into COPII vesicles.","evidence":"Cytoplasmic-tail deletion/substitution mutagenesis with COPII colocalization and surface biotinylation/transport assays","pmids":["15475566"],"confidence":"High","gaps":["COPII coat component that reads the valine signal not identified","Whether trafficking is regulated to tune surface ligand levels unknown"]},{"year":2007,"claim":"Consolidated the receptor-proximal mechanism: KITLG drives c-Kit dimerization and autophosphorylation feeding into multiple defined signaling pathways.","evidence":"Review integrating c-Kit dimerization, autophosphorylation, and downstream pathway and juxtamembrane mutation analyses","pmids":["17659849"],"confidence":"Low","gaps":["No primary new data in this paper","Pathway selection across cell types not addressed"]},{"year":2008,"claim":"Extended KITLG function into the tumor microenvironment, showing concentration-dependent control of mast cell chemotaxis versus activation and downstream immunosuppression.","evidence":"In vitro mast cell chemotaxis/activation assays, NF-κB/AP-1 reporters, and Treg suppression assays with recombinant SCF","pmids":["18524989"],"confidence":"Medium","gaps":["In vivo relevance of the concentration thresholds not established","Whether soluble or membrane KITLG drives this in tumors unclear"]},{"year":2008,"claim":"Demonstrated that KITLG supplementation rescues follicle loss, establishing KIT/KITL signaling as a survival factor for ovarian primordial and primary follicles.","evidence":"In vivo VCD dosing plus in vitro ovarian culture with exogenous KITL rescue, microarray, qPCR, Western blot","pmids":["18448842"],"confidence":"Medium","gaps":["Signaling pathway mediating follicle survival not dissected here","Mechanism of compensatory Kitl upregulation unknown"]},{"year":2009,"claim":"Showed KITLG can act as a brake on proliferation and a driver of differentiation in a non-hematopoietic tissue, attenuating IGF-I/ERK signaling in chondrocytes.","evidence":"Growth plate chondrocyte and ATDC5 cultures with proliferation, ERK1/2 phospho-Westerns, and differentiation markers","pmids":["19897599"],"confidence":"Medium","gaps":["Mechanism by which KITLG attenuates IGF-I-driven ERK not defined","In vivo skeletal relevance not tested"]},{"year":2011,"claim":"Identified KITLG mutations in a conserved beta-strand as a cause of human progressive pigmentation disorders, translating ligand structure-function to human disease.","evidence":"Genome-wide linkage and mutation co-segregation analysis across seven families with FPHH","pmids":["21368769"],"confidence":"Low","gaps":["No functional validation of mutation effect on c-Kit activation in this study","Mechanism (gain vs loss of function) not resolved"]},{"year":2015,"claim":"Established KITLG as a Mendelian deafness/Waardenburg gene and linked specific mutations to defective surface localization or impaired soluble ligand shedding, distinguishing loss-of-function from dominant-negative mechanisms.","evidence":"Transfection of mutant constructs with surface localization assays and ELISA for soluble KITLG","pmids":["26522471"],"confidence":"Medium","gaps":["Shedding machinery affected by the WS2 mutation not identified","In vivo confirmation of dominant-negative mechanism lacking"]},{"year":2015,"claim":"Showed KITLG operates as an alternative, ERBB-independent effector pathway for retinoic-acid-induced spermatogonial differentiation, refining its germline role.","evidence":"Soma-free spermatogonial culture with ERBB2 inhibitor and ERBB3-deficient cells under retinoic acid","pmids":["26500786"],"confidence":"Medium","gaps":["Intracellular signaling distinguishing KITL from NRG1/ERBB pathways not mapped","Source of KITL in soma-free system unclear"]},{"year":2015,"claim":"Defined direct transcriptional control of KITLG by HIF-1α, placing the ligand downstream of hypoxia signaling to promote tumor progression.","evidence":"ChIP and luciferase reporter on the KITLG promoter HRE, RNAi, and SCF rescue after HIF-1α knockdown in PDAC with xenografts","pmids":["25799412"],"confidence":"Medium","gaps":["Whether tumor cell-autonomous or paracrine c-Kit signaling mediates the effect not resolved","Single cancer context"]},{"year":2015,"claim":"Identified miR-34c as a direct 3'UTR repressor of KITLG, embedding the ligand in a resveratrol-responsive anti-cancer regulatory axis.","evidence":"Luciferase 3'UTR assay, lentiviral miR-34c gain/loss-of-function with KITLG readout, colorectal xenografts","pmids":["26674205"],"confidence":"Medium","gaps":["Physiological contexts where miR-34c sets KITLG levels not defined","Other 3'UTR regulators not surveyed"]},{"year":2017,"claim":"Ordered MAPK3/1 upstream of an mTORC1-KITL axis in primordial follicle activation, linking somatic ERK signaling to oocyte Akt/Foxo3 control via the ligand.","evidence":"Neonatal ovary culture with U0126 and PTEN inhibitor, Western blots of Tsc2/S6K1/rpS6/Akt, and follicle counting","pmids":["28218391"],"confidence":"Medium","gaps":["Direct transcriptional mechanism by which mTORC1 controls KITL not shown","In vivo genetic confirmation lacking"]},{"year":2017,"claim":"Associated environmental cadmium with altered kitl isoform ratios via splicing and a candidate miRNA program, implicating post-transcriptional control of KITLG isoforms.","evidence":"Granulosa cell Cd exposure with isoform-specific RT-PCR and miRNA microarray","pmids":["28892167"],"confidence":"Low","gaps":["Associative miRNA-splicing correlation without functional validation","No demonstration that named miRNAs control kitl splicing directly"]},{"year":2019,"claim":"Defined a discrete biochemical mechanism for KITLG-driven pathological angiogenesis through GSK-3β phosphorylation and β-catenin nuclear translocation, validated genetically and pharmacologically in vivo.","evidence":"cKit mutant mice, anti-SCF antibody, β-catenin inhibitors/agonist rescue, GSK-3β/β-catenin Westerns, OIR and laser-CNV models","pmids":["31434494"],"confidence":"High","gaps":["How c-Kit activation links to GSK-3β phosphorylation mechanistically not detailed","Relative contribution of canonical PI3K/MAPK branches not separated"]},{"year":2019,"claim":"Confirmed miR-27a as a direct 3'UTR repressor of KITLG that inversely correlates with KITLG in pigmented tissue, reinforcing post-transcriptional control of ligand levels.","evidence":"Luciferase 3'UTR assay, miR-27a overexpression in HEK-293T, and Western/qRT-PCR in goat skin","pmids":["31613171"],"confidence":"Medium","gaps":["Functional consequence for pigmentation not directly tested","Whether miR-27a regulation operates in human tissue unknown"]},{"year":2023,"claim":"Identified Gαi1/Gαi3 as physical partners of activated c-Kit required for receptor endocytosis and propagation of SCF-induced Akt-mTOR and ERK signaling, revealing a heterotrimeric G-protein requirement in this RTK pathway.","evidence":"Reciprocal Co-IP of Gαi1/3 with c-Kit, siRNA/KO/dominant-negative perturbation, phospho-Westerns, HUVEC assays, and AAV-shRNA in retinal angiogenesis models","pmids":["37063428"],"confidence":"High","gaps":["How Gαi proteins are recruited to c-Kit not defined","Whether this requirement extends beyond endothelial cells unknown"]},{"year":null,"claim":"How distinct KITLG-c-Kit signaling outputs (PI3K/Akt vs ERK vs JAK/STAT) are selected to produce lineage-specific outcomes across hematopoietic, germline, melanocyte, and vascular contexts remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking isoform choice and adaptor usage to pathway selection","No structural model of the human KITLG-c-Kit complex in the corpus","Tissue-specific determinants of soluble vs membrane KITLG signaling undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[1,8,18]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,8,18]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,7,13]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[7,13]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,2,13]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,8,17,18]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,4,10,16]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[1,3,9]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[13,14,17]},{"term_id":"R-HSA-1474165","term_label":"Reproduction","supporting_discovery_ids":[0,10,15,16]}],"complexes":[],"partners":["KIT","GAB2","GNAI1","GNAI3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P21583","full_name":"Kit ligand","aliases":["Mast cell growth factor","MGF","Stem cell factor","SCF","c-Kit ligand"],"length_aa":273,"mass_kda":30.9,"function":"Ligand for the receptor-type protein-tyrosine kinase KIT. Plays an essential role in the regulation of cell survival and proliferation, hematopoiesis, stem cell maintenance, gametogenesis, mast cell development, migration and function, and in melanogenesis. KITLG/SCF binding can activate several signaling pathways. Promotes phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, and subsequent activation of the kinase AKT1. KITLG/SCF and KIT also transmit signals via GRB2 and activation of RAS, RAF1 and the MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1. KITLG/SCF and KIT promote activation of STAT family members STAT1, STAT3 and STAT5. KITLG/SCF and KIT promote activation of PLCG1, leading to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. KITLG/SCF acts synergistically with other cytokines, probably interleukins","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P21583/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KITLG","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KITLG","total_profiled":1310},"omim":[{"mim_id":"621205","title":"MICRO RNA 129-2; MIR129-2","url":"https://www.omim.org/entry/621205"},{"mim_id":"621204","title":"MICRO RNA 129-1; MIR129-1","url":"https://www.omim.org/entry/621204"},{"mim_id":"619947","title":"WAARDENBURG SYNDROME, TYPE 2F; WS2F","url":"https://www.omim.org/entry/619947"},{"mim_id":"616697","title":"DEAFNESS, AUTOSOMAL DOMINANT 69; DFNA69","url":"https://www.omim.org/entry/616697"},{"mim_id":"612839","title":"TET METHYLCYTOSINE DIOXYGENASE 2; TET2","url":"https://www.omim.org/entry/612839"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/KITLG"},"hgnc":{"alias_symbol":["SCF","SF","Kitl","KL-1","FPH2","SLF","DFNA69"],"prev_symbol":["MGF"]},"alphafold":{"accession":"P21583","domains":[{"cath_id":"1.20.1250.10","chopping":"27-157","consensus_level":"medium","plddt":85.3634,"start":27,"end":157},{"cath_id":"1.20.5","chopping":"232-273","consensus_level":"medium","plddt":64.8219,"start":232,"end":273}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P21583","model_url":"https://alphafold.ebi.ac.uk/files/AF-P21583-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P21583-F1-predicted_aligned_error_v6.png","plddt_mean":71.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KITLG","jax_strain_url":"https://www.jax.org/strain/search?query=KITLG"},"sequence":{"accession":"P21583","fasta_url":"https://rest.uniprot.org/uniprotkb/P21583.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P21583/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P21583"}},"corpus_meta":[{"pmid":"17637677","id":"PMC_17637677","title":"JAZ repressor proteins are targets of the SCF(COI1) complex during jasmonate signalling.","date":"2007","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/17637677","citation_count":1819,"is_preprint":false},{"pmid":"20048001","id":"PMC_20048001","title":"A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP).","date":"2010","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/20048001","citation_count":1230,"is_preprint":false},{"pmid":"10611969","id":"PMC_10611969","title":"SCF and Cullin/Ring H2-based ubiquitin ligases.","date":"1999","source":"Annual review of cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10611969","citation_count":1015,"is_preprint":false},{"pmid":"24336215","id":"PMC_24336215","title":"D14-SCF(D3)-dependent degradation of D53 regulates strigolactone signalling.","date":"2013","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/24336215","citation_count":642,"is_preprint":false},{"pmid":"15571813","id":"PMC_15571813","title":"A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin.","date":"2004","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/15571813","citation_count":395,"is_preprint":false},{"pmid":"25394868","id":"PMC_25394868","title":"SCF ubiquitin ligase-targeted therapies.","date":"2014","source":"Nature reviews. Drug discovery","url":"https://pubmed.ncbi.nlm.nih.gov/25394868","citation_count":296,"is_preprint":false},{"pmid":"15840441","id":"PMC_15840441","title":"Regulation of the cell cycle by SCF-type ubiquitin ligases.","date":"2005","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/15840441","citation_count":286,"is_preprint":false},{"pmid":"19483682","id":"PMC_19483682","title":"Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer.","date":"2009","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19483682","citation_count":270,"is_preprint":false},{"pmid":"18524989","id":"PMC_18524989","title":"SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18524989","citation_count":269,"is_preprint":false},{"pmid":"15380093","id":"PMC_15380093","title":"APC/C and SCF: controlling each other and the cell cycle.","date":"2004","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/15380093","citation_count":237,"is_preprint":false},{"pmid":"9914180","id":"PMC_9914180","title":"SCF and APC: the Yin and Yang of cell cycle regulated proteolysis.","date":"1998","source":"Current opinion in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9914180","citation_count":220,"is_preprint":false},{"pmid":"7677988","id":"PMC_7677988","title":"Follicle-stimulating hormone induction of steel factor (SLF) mRNA in mouse Sertoli cells and stimulation of DNA synthesis in spermatogonia by soluble SLF.","date":"1993","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/7677988","citation_count":182,"is_preprint":false},{"pmid":"15546359","id":"PMC_15546359","title":"The IAA1 protein is encoded by AXR5 and is a substrate of SCF(TIR1).","date":"2004","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15546359","citation_count":163,"is_preprint":false},{"pmid":"15838520","id":"PMC_15838520","title":"SCF-mediated protein degradation and cell cycle control.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15838520","citation_count":153,"is_preprint":false},{"pmid":"11764276","id":"PMC_11764276","title":"Review: melanocyte migration and survival controlled by SCF/c-kit expression.","date":"2001","source":"The journal of investigative dermatology. Symposium proceedings","url":"https://pubmed.ncbi.nlm.nih.gov/11764276","citation_count":145,"is_preprint":false},{"pmid":"9529603","id":"PMC_9529603","title":"Proteolysis and the G1-S transition: the SCF connection.","date":"1998","source":"Current opinion in genetics & development","url":"https://pubmed.ncbi.nlm.nih.gov/9529603","citation_count":140,"is_preprint":false},{"pmid":"21247385","id":"PMC_21247385","title":"SCF E3 ubiquitin ligases as anticancer targets.","date":"2011","source":"Current cancer drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/21247385","citation_count":121,"is_preprint":false},{"pmid":"29103612","id":"PMC_29103612","title":"Composition and Regulation of the Cellular Repertoire of SCF Ubiquitin Ligases.","date":"2017","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/29103612","citation_count":120,"is_preprint":false},{"pmid":"11861309","id":"PMC_11861309","title":"Requirement of Gab2 for mast cell development and KitL/c-Kit signaling.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11861309","citation_count":113,"is_preprint":false},{"pmid":"10582239","id":"PMC_10582239","title":"SCF ubiquitin protein ligases and phosphorylation-dependent proteolysis.","date":"1999","source":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/10582239","citation_count":101,"is_preprint":false},{"pmid":"16131838","id":"PMC_16131838","title":"Mechanisms of tumor suppression by the SCF(Fbw7).","date":"2005","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/16131838","citation_count":100,"is_preprint":false},{"pmid":"26868148","id":"PMC_26868148","title":"SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26868148","citation_count":97,"is_preprint":false},{"pmid":"31898225","id":"PMC_31898225","title":"The Biology of F-box Proteins: The SCF Family of E3 Ubiquitin Ligases.","date":"2020","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/31898225","citation_count":89,"is_preprint":false},{"pmid":"27156687","id":"PMC_27156687","title":"Recent advances in SCF ubiquitin ligase complex: Clinical implications.","date":"2016","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/27156687","citation_count":85,"is_preprint":false},{"pmid":"26818844","id":"PMC_26818844","title":"SCF(Cyclin F)-dependent degradation of CDC6 suppresses DNA re-replication.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26818844","citation_count":84,"is_preprint":false},{"pmid":"23528706","id":"PMC_23528706","title":"Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases.","date":"2013","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/23528706","citation_count":79,"is_preprint":false},{"pmid":"28218391","id":"PMC_28218391","title":"MAPK3/1 participates in the activation of primordial follicles through mTORC1-KITL signaling.","date":"2017","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28218391","citation_count":74,"is_preprint":false},{"pmid":"10996795","id":"PMC_10996795","title":"The SCF ubiquitin ligase protein slimb regulates centrosome duplication in Drosophila.","date":"2000","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/10996795","citation_count":74,"is_preprint":false},{"pmid":"26674205","id":"PMC_26674205","title":"Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.","date":"2015","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26674205","citation_count":73,"is_preprint":false},{"pmid":"17166256","id":"PMC_17166256","title":"F-box proteins: more than baits for the SCF?","date":"2006","source":"Cell division","url":"https://pubmed.ncbi.nlm.nih.gov/17166256","citation_count":66,"is_preprint":false},{"pmid":"17659849","id":"PMC_17659849","title":"Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST).","date":"2007","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/17659849","citation_count":66,"is_preprint":false},{"pmid":"30177679","id":"PMC_30177679","title":"SCFFBW7-mediated degradation of Brg1 suppresses gastric cancer metastasis.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30177679","citation_count":66,"is_preprint":false},{"pmid":"16709194","id":"PMC_16709194","title":"AhSSK1, a novel SKP1-like protein that interacts with the S-locus F-box protein SLF.","date":"2006","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16709194","citation_count":64,"is_preprint":false},{"pmid":"21617256","id":"PMC_21617256","title":"Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour.","date":"2011","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21617256","citation_count":64,"is_preprint":false},{"pmid":"14997053","id":"PMC_14997053","title":"c-kit and SCF expression in normal and tumor breast tissue.","date":"2004","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/14997053","citation_count":63,"is_preprint":false},{"pmid":"18024566","id":"PMC_18024566","title":"Comparison of Petunia inflata S-Locus F-box protein (Pi SLF) with Pi SLF like proteins reveals its unique function in S-RNase based self-incompatibility.","date":"2007","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/18024566","citation_count":57,"is_preprint":false},{"pmid":"27234298","id":"PMC_27234298","title":"SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development.","date":"2016","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/27234298","citation_count":57,"is_preprint":false},{"pmid":"23324393","id":"PMC_23324393","title":"An SCF complex containing Fbxl12 mediates DNA damage-induced Ku80 ubiquitylation.","date":"2013","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/23324393","citation_count":55,"is_preprint":false},{"pmid":"11076095","id":"PMC_11076095","title":"Stem cell factor (SCF) concentrations in peritoneal fluid of women with or without endometriosis.","date":"2000","source":"American journal of reproductive immunology (New York, N.Y. : 1989)","url":"https://pubmed.ncbi.nlm.nih.gov/11076095","citation_count":53,"is_preprint":false},{"pmid":"26522471","id":"PMC_26522471","title":"Allelic Mutations of KITLG, Encoding KIT Ligand, Cause Asymmetric and Unilateral Hearing Loss and Waardenburg Syndrome Type 2.","date":"2015","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26522471","citation_count":53,"is_preprint":false},{"pmid":"21368769","id":"PMC_21368769","title":"KITLG mutations cause familial progressive hyper- and hypopigmentation.","date":"2011","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/21368769","citation_count":52,"is_preprint":false},{"pmid":"16275325","id":"PMC_16275325","title":"High-level expression and purification of recombinant SCF ubiquitin ligases.","date":"2005","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/16275325","citation_count":46,"is_preprint":false},{"pmid":"1280935","id":"PMC_1280935","title":"Analyzing mast cell development and function using mice carrying mutations at W/c-kit or Sl/MGF (SCF) loci.","date":"1992","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/1280935","citation_count":46,"is_preprint":false},{"pmid":"24778256","id":"PMC_24778256","title":"Crumbs promotes expanded recognition and degradation by the SCF(Slimb/β-TrCP) ubiquitin ligase.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24778256","citation_count":45,"is_preprint":false},{"pmid":"22072546","id":"PMC_22072546","title":"Associations between variants in KITLG, SPRY4, BAK1, and DMRT1 and pediatric germ cell tumors.","date":"2011","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22072546","citation_count":44,"is_preprint":false},{"pmid":"21566575","id":"PMC_21566575","title":"The genetic determination of skin pigmentation: KITLG and the KITLG/c-Kit pathway as key players in the onset of human familial pigmentary diseases.","date":"2011","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/21566575","citation_count":43,"is_preprint":false},{"pmid":"28656507","id":"PMC_28656507","title":"The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer.","date":"2017","source":"Journal of cell communication and signaling","url":"https://pubmed.ncbi.nlm.nih.gov/28656507","citation_count":43,"is_preprint":false},{"pmid":"23522382","id":"PMC_23522382","title":"Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.","date":"2013","source":"Journal of genetics and genomics = Yi chuan xue bao","url":"https://pubmed.ncbi.nlm.nih.gov/23522382","citation_count":42,"is_preprint":false},{"pmid":"12152985","id":"PMC_12152985","title":"The synergy between stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF): molecular basis and clinical relevance.","date":"2002","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/12152985","citation_count":41,"is_preprint":false},{"pmid":"34445249","id":"PMC_34445249","title":"The SCF Complex Is Essential to Maintain Genome and Chromosome Stability.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34445249","citation_count":40,"is_preprint":false},{"pmid":"17947432","id":"PMC_17947432","title":"Expression of 10 S-class SLF-like genes in Nicotiana alata pollen and its implications for understanding the pollen factor of the S locus.","date":"2007","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17947432","citation_count":40,"is_preprint":false},{"pmid":"25359157","id":"PMC_25359157","title":"The SCF/c-KIT system in the male: Survival strategies in fertility and cancer.","date":"2014","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/25359157","citation_count":39,"is_preprint":false},{"pmid":"18340346","id":"PMC_18340346","title":"The SCF FSN-1 ubiquitin ligase controls germline apoptosis through CEP-1/p53 in C. elegans.","date":"2008","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/18340346","citation_count":39,"is_preprint":false},{"pmid":"37028429","id":"PMC_37028429","title":"Systemwide disassembly and assembly of SCF ubiquitin ligase complexes.","date":"2023","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/37028429","citation_count":38,"is_preprint":false},{"pmid":"26666832","id":"PMC_26666832","title":"SCF(β-TRCP) promotes cell growth by targeting PR-Set7/Set8 for degradation.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26666832","citation_count":38,"is_preprint":false},{"pmid":"25799412","id":"PMC_25799412","title":"SCF, regulated by HIF-1α, promotes pancreatic ductal adenocarcinoma cell progression.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25799412","citation_count":38,"is_preprint":false},{"pmid":"20230746","id":"PMC_20230746","title":"Hsk1- and SCF(Pof3)-dependent proteolysis of S. pombe Ams2 ensures histone homeostasis and centromere function.","date":"2010","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/20230746","citation_count":38,"is_preprint":false},{"pmid":"31898226","id":"PMC_31898226","title":"Targeting SCF E3 Ligases for Cancer Therapies.","date":"2020","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/31898226","citation_count":37,"is_preprint":false},{"pmid":"26560120","id":"PMC_26560120","title":"The SCF-type E3 Ubiquitin Ligases as Cancer Targets.","date":"2016","source":"Current cancer drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/26560120","citation_count":37,"is_preprint":false},{"pmid":"7684700","id":"PMC_7684700","title":"Responses of the murine myeloid cell line FDC-P1 to soluble and membrane-bound forms of steel factor (SLF).","date":"1993","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/7684700","citation_count":36,"is_preprint":false},{"pmid":"12429941","id":"PMC_12429941","title":"Seek and destroy: SCF ubiquitin ligases in mammalian cell cycle control.","date":"2002","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/12429941","citation_count":36,"is_preprint":false},{"pmid":"18448842","id":"PMC_18448842","title":"Involvement of the KIT/KITL signaling pathway in 4-vinylcyclohexene diepoxide-induced ovarian follicle loss in rats.","date":"2008","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/18448842","citation_count":35,"is_preprint":false},{"pmid":"19897599","id":"PMC_19897599","title":"SCF, BDNF, and Gas6 are regulators of growth plate chondrocyte proliferation and differentiation.","date":"2009","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/19897599","citation_count":34,"is_preprint":false},{"pmid":"18818515","id":"PMC_18818515","title":"SCF(Fbx4/alphaB-crystallin) E3 ligase: when one is not enough.","date":"2008","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/18818515","citation_count":33,"is_preprint":false},{"pmid":"27108110","id":"PMC_27108110","title":"Stem Cell Factor (SCF) is a putative biomarker of antidepressant response.","date":"2016","source":"Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27108110","citation_count":33,"is_preprint":false},{"pmid":"28406060","id":"PMC_28406060","title":"Auxin signaling through SCFTIR1/AFBs mediates feedback regulation of IAA biosynthesis.","date":"2017","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28406060","citation_count":32,"is_preprint":false},{"pmid":"26008799","id":"PMC_26008799","title":"Expression and localisation of c-kit and KITL in the adult human ovary.","date":"2015","source":"Journal of ovarian research","url":"https://pubmed.ncbi.nlm.nih.gov/26008799","citation_count":30,"is_preprint":false},{"pmid":"23263858","id":"PMC_23263858","title":"Identification of a canonical SCF(SLF) complex involved in S-RNase-based self-incompatibility of Pyrus (Rosaceae).","date":"2012","source":"Plant molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23263858","citation_count":30,"is_preprint":false},{"pmid":"19679664","id":"PMC_19679664","title":"Adenovirus E1A inhibits SCF(Fbw7) ubiquitin ligase.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19679664","citation_count":30,"is_preprint":false},{"pmid":"31451788","id":"PMC_31451788","title":"Notch and the pre-TCR coordinate thymocyte proliferation by induction of the SCF subunits Fbxl1 and Fbxl12.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31451788","citation_count":30,"is_preprint":false},{"pmid":"32032354","id":"PMC_32032354","title":"Skp, Cullin, F-box (SCF)-Met30 and SCF-Cdc4-Mediated Proteolysis of CENP-A Prevents Mislocalization of CENP-A for Chromosomal Stability in Budding Yeast.","date":"2020","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32032354","citation_count":29,"is_preprint":false},{"pmid":"27238229","id":"PMC_27238229","title":"Skp1: Implications in cancer and SCF-oriented anti-cancer drug discovery.","date":"2016","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/27238229","citation_count":28,"is_preprint":false},{"pmid":"31289136","id":"PMC_31289136","title":"SCFFBXW7/GSK3β-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells.","date":"2019","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/31289136","citation_count":28,"is_preprint":false},{"pmid":"24038146","id":"PMC_24038146","title":"PLCγ2 and PKC are important to myeloid lineage commitment triggered by M-SCF and G-CSF.","date":"2014","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24038146","citation_count":27,"is_preprint":false},{"pmid":"29496961","id":"PMC_29496961","title":"MAPK signaling couples SCF-mediated degradation of translational regulators to oocyte meiotic progression.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29496961","citation_count":26,"is_preprint":false},{"pmid":"28892167","id":"PMC_28892167","title":"Effect of cadmium on kitl pre-mRNA alternative splicing in murine ovarian granulosa cells and its associated regulation by miRNAs.","date":"2017","source":"Journal of applied toxicology : JAT","url":"https://pubmed.ncbi.nlm.nih.gov/28892167","citation_count":26,"is_preprint":false},{"pmid":"31434494","id":"PMC_31434494","title":"SCF (Stem Cell Factor) and cKIT Modulate Pathological Ocular Neovascularization.","date":"2019","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31434494","citation_count":25,"is_preprint":false},{"pmid":"17224055","id":"PMC_17224055","title":"SCF Fbx4/alphaB-crystallin cyclin D1 ubiquitin ligase: a license to destroy.","date":"2007","source":"Cell division","url":"https://pubmed.ncbi.nlm.nih.gov/17224055","citation_count":25,"is_preprint":false},{"pmid":"30655559","id":"PMC_30655559","title":"The circadian E3 ligase complex SCFFBXL3+CRY targets TLK2.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30655559","citation_count":25,"is_preprint":false},{"pmid":"37063428","id":"PMC_37063428","title":"SCF/c-Kit-activated signaling and angiogenesis require Gαi1 and Gαi3.","date":"2023","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37063428","citation_count":24,"is_preprint":false},{"pmid":"12242245","id":"PMC_12242245","title":"An allelic series of mutations in the Kit ligand gene of mice. II. Effects of ethylnitrosourea-induced Kitl point mutations on survival and peripheral blood cells of Kitl(Steel) mice.","date":"2002","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12242245","citation_count":24,"is_preprint":false},{"pmid":"33156518","id":"PMC_33156518","title":"SCFSNIPER7 controls protein turnover of unfoldase CDC48A to promote plant immunity.","date":"2020","source":"The New phytologist","url":"https://pubmed.ncbi.nlm.nih.gov/33156518","citation_count":23,"is_preprint":false},{"pmid":"39880951","id":"PMC_39880951","title":"C-terminal amides mark proteins for degradation via SCF-FBXO31.","date":"2025","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/39880951","citation_count":22,"is_preprint":false},{"pmid":"31613171","id":"PMC_31613171","title":"MiR-27a regulates WNT3A and KITLG expression in Cashmere goats with different coat colors.","date":"2019","source":"Animal biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/31613171","citation_count":22,"is_preprint":false},{"pmid":"15475566","id":"PMC_15475566","title":"A specific endoplasmic reticulum export signal drives transport of stem cell factor (Kitl) to the cell surface.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15475566","citation_count":22,"is_preprint":false},{"pmid":"12242244","id":"PMC_12242244","title":"An allelic series of mutations in the kit ligand gene of mice. I. Identification of point mutations in seven ethylnitrosourea-induced Kitl(Steel) alleles.","date":"2002","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12242244","citation_count":22,"is_preprint":false},{"pmid":"25425648","id":"PMC_25425648","title":"Ubiquitin-conjugating enzyme Cdc34 and ubiquitin ligase Skp1-cullin-F-box ligase (SCF) interact through multiple conformations.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25425648","citation_count":22,"is_preprint":false},{"pmid":"22454292","id":"PMC_22454292","title":"DEPTOR ubiquitination and destruction by SCF(β-TrCP).","date":"2012","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/22454292","citation_count":21,"is_preprint":false},{"pmid":"30762924","id":"PMC_30762924","title":"Spironolactone-induced XPB degradation depends on CDK7 kinase and SCFFBXL18 E3 ligase.","date":"2019","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/30762924","citation_count":21,"is_preprint":false},{"pmid":"35140718","id":"PMC_35140718","title":"Autocrine/Paracrine Loop Between SCF+/c-Kit+ Mast Cells Promotes Cutaneous Melanoma Progression.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35140718","citation_count":20,"is_preprint":false},{"pmid":"29099936","id":"PMC_29099936","title":"Genomic Analysis Suggests KITLG is Responsible for a Roan Pattern in two Pakistani Goat Breeds.","date":"2018","source":"The Journal of heredity","url":"https://pubmed.ncbi.nlm.nih.gov/29099936","citation_count":20,"is_preprint":false},{"pmid":"37339624","id":"PMC_37339624","title":"Structural and mechanistic insights into the CAND1-mediated SCF substrate receptor exchange.","date":"2023","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/37339624","citation_count":19,"is_preprint":false},{"pmid":"32463597","id":"PMC_32463597","title":"High expression of KITLG is a new hallmark activating the MAPK pathway in type A and AB thymoma.","date":"2020","source":"Thoracic cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32463597","citation_count":19,"is_preprint":false},{"pmid":"26500786","id":"PMC_26500786","title":"NRG1 and KITL Signal Downstream of Retinoic Acid in the Germline to Support Soma-Free Syncytial Growth of Differentiating Spermatogonia.","date":"2015","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/26500786","citation_count":19,"is_preprint":false},{"pmid":"35231559","id":"PMC_35231559","title":"TDP-43 is a ubiquitylation substrate of the SCFcyclin F complex.","date":"2022","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/35231559","citation_count":19,"is_preprint":false},{"pmid":"26400522","id":"PMC_26400522","title":"DNA damage regulates ARID1A stability via SCF ubiquitin ligase in gastric cancer cells.","date":"2015","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26400522","citation_count":19,"is_preprint":false},{"pmid":"30728155","id":"PMC_30728155","title":"Stratifin Inhibits SCFFBW7 Formation and Blocks Ubiquitination of Oncoproteins during the Course of Lung Adenocarcinogenesis.","date":"2019","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/30728155","citation_count":18,"is_preprint":false},{"pmid":"21710433","id":"PMC_21710433","title":"Regulation of cell fate determination by Skp1-Cullin1-F-box (SCF) E3 ubiquitin ligases.","date":"2011","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21710433","citation_count":17,"is_preprint":false},{"pmid":"25217643","id":"PMC_25217643","title":"Ras regulates SCF(β-TrCP) protein activity and specificity via its effector protein NORE1A.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25217643","citation_count":17,"is_preprint":false},{"pmid":"23680451","id":"PMC_23680451","title":"New insights on the function of SCF ubiquitin E3 ligases in the lung.","date":"2013","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/23680451","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46432,"output_tokens":7574,"usd":0.126453,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15542,"output_tokens":6510,"usd":0.12023,"stage2_stop_reason":"end_turn"},"total_usd":0.246683,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"Looking at the corpus, I need to identify papers about the canonical KITLG gene (also known as SCF/Kitl/KL-1/FPH2/SLF/DFNA69 — the Kit ligand / stem cell factor protein) and extract mechanistic findings.\n\nThe vast majority of papers in this corpus are about SCF as \"Skp1-Cullin-F-box\" ubiquitin ligase complexes — a completely different molecular entity. I need to carefully separate:\n- KITLG/SCF = stem cell factor / Kit ligand (the cytokine that binds c-Kit receptor)\n- SCF = Skp1-Cullin-F-box ubiquitin ligase complex (unrelated)\n\nPapers clearly about KITLG (Kit ligand/stem cell factor):\n- PMID:7677988 (FSH induction of SLF in Sertoli cells, DNA synthesis in spermatogonia)\n- PMID:11861309 (Gab2 required for KitL/c-Kit signaling and mast cell development)\n- PMID:18524989 (SCF/KITLG mediates mast cell infiltration via c-Kit)\n- PMID:11764276 (melanocyte migration/survival, SCF/c-kit)\n- PMID:17659849 (c-kit/SCF in GIST, receptor dimerization/autophosphorylation)\n- PMID:26522471 (KITLG mutations, cell membrane localization, soluble isoform)\n- PMID:21368769 (KITLG mutations in pigmentation)\n- PMID:28218391 (MAPK3/1-mTORC1-KITL signaling in primordial follicle activation)\n- PMID:18448842 (KIT/KITL signaling in ovarian follicle survival)\n- PMID:15475566 (ER export signal in Kitl cytoplasmic tail, COPII recruitment)\n- PMID:12242245 and PMID:12242244 (ENU allelic series of Kitl mutations)\n- PMID:25359157 (SCF/c-KIT system review — signaling pathways PI3K, Src, JAK/STAT, MAPK)\n- PMID:28656507 (SCF/c-KIT signaling pathways review)\n- PMID:7684700 (membrane-bound vs soluble SLF, FDC-P1 cells)\n- PMID:1280935 (mast cell development, W/Wv mice, c-kit/SCF)\n- PMID:25799412 (HIF-1α regulates SCF/KITLG transcription in PDAC)\n- PMID:19897599 (SCF inhibits IGF-I-mediated ERK1/2, promotes chondrocyte differentiation)\n- PMID:12152985 (SCF synergy with G-CSF, p27kip1 downregulation, STAT3 phosphorylation)\n- PMID:31434494 (SCF/cKIT signaling via GSK-3β/β-catenin in ocular neovascularization)\n- PMID:37063428 (Gαi1/3 associate with c-Kit, promote endocytosis, transduce downstream signaling)\n- PMID:26008799 (c-kit/KITL expression/localization in human ovary)\n- PMID:26500786 (KITL supports spermatogonial differentiation, alternative pathway to ERBB2/3)\n- PMID:28892167 (Cd affects kitl pre-mRNA alternative splicing)\n- PMID:26674205 (miR-34c targets KITLG in CRC)\n- PMID:31613171 (miR-27a targets KITLG in goat coat color)\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"FSH and its intracellular mediator cAMP increase mRNA levels for Steel factor (SLF/KITLG) — both the soluble and transmembrane isoforms — in cultured mouse Sertoli cells. Soluble recombinant SLF selectively stimulates DNA synthesis in type A spermatogonia in a dose-dependent manner, independent of serum.\",\n      \"method\": \"Primary Sertoli cell culture with FSH/cAMP treatment, PCR for isoform-specific mRNA detection, [3H]-thymidine incorporation assay in isolated spermatogonial populations, autoradiography\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional assay (DNA synthesis) with defined ligand, isoform-specific PCR, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"7677988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"SCF (KITLG) is the major migration, survival, proliferation, and maturation factor for mast cell precursors acting through the c-Kit tyrosine kinase receptor. W/Wv mice lacking functional c-Kit virtually lack tissue mast cells, establishing that the KITLG/c-Kit axis is essential for mast cell development in vivo.\",\n      \"method\": \"Genetic mouse models (W/Wv loss-of-function), adoptive transfer / mast cell reconstitution experiments in multiple tissues\",\n      \"journal\": \"Annals of the New York Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with defined loss-of-function phenotype replicated across tissues; foundational work replicated across multiple labs\",\n      \"pmids\": [\"1280935\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Membrane-bound SLF (KITLG transmembrane isoform) — but not soluble SLF — can support sustained proliferation of FDC-P1 myeloid cells expressing c-Kit on fibroblast co-culture. The Sl/Sld mutant fibroblasts producing only soluble SLF fail to support these cells, demonstrating a functional distinction between membrane-bound and soluble KITLG isoforms. GM-CSF and IL-3 downregulate surface c-Kit expression in a unidirectional manner, reducing responsiveness to SLF.\",\n      \"method\": \"Fibroblast co-culture with neutralizing antibodies against GM-CSF, Sl/Sld mutant fibroblasts (soluble SLF only), cell adaptation assay, c-kit mRNA quantification, surface c-Kit protein measurement\",\n      \"journal\": \"Experimental hematology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal genetic/cell biological comparison of isoforms, single lab with multiple orthogonal approaches\",\n      \"pmids\": [\"7684700\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Gab2 adaptor protein is required for KitL/c-Kit signaling and mast cell development. In Gab2-deficient mice, mast cell numbers are markedly reduced, and bone marrow-derived mast cells grow poorly in response to KITLG. KITLG-induced ERK MAP kinase and Akt activation are both impaired in Gab2-deficient cells, placing Gab2 downstream of c-Kit in the KITLG signaling cascade.\",\n      \"method\": \"Gab2 knockout mice, bone marrow-derived mast cell culture with KitL, flow cytometry for mast cell numbers, ERK and Akt phosphorylation assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic KO with defined cellular phenotype plus defined downstream signaling readouts (ERK, Akt), reciprocal functional evidence\",\n      \"pmids\": [\"11861309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"KITLG (SCF) and its receptor c-Kit control multiple stages of melanocyte migration and survival during mouse ontogeny. Spatiotemporally specific expression of SCF in the dermis is required for c-Kit-dependent melanocyte colonization; SCF transgene expression rescues specific stages of melanocyte development, and functional c-Kit blockade by monoclonal antibody identifies distinct c-Kit-dependent and c-Kit-independent developmental stages.\",\n      \"method\": \"SCF transgenic mice, anti-c-Kit monoclonal antibody functional blockade, white spotting mutant (Sl/W) mouse analysis, immunohistochemistry\",\n      \"journal\": \"The journal of investigative dermatology. Symposium proceedings\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic rescue and antibody blockade in vivo, single lab, multiple genetic approaches\",\n      \"pmids\": [\"11764276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Seven ENU-induced point mutations in Kitl (KITLG) at the Steel locus were characterized; five are missense mutations each affecting residues within or near conserved alpha-helical domains of KITLG. This establishes that the helical domain residues are structurally required for KITLG function, as homozygous mutations cause severe anemia and lethality correlated with mutation severity.\",\n      \"method\": \"ENU mutagenesis screen, DNA sequencing of Kitl alleles, phenotypic analysis of peripheral blood and pigmentation in heterozygous and homozygous mice\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — allelic series with in vivo phenotype correlation to mutation site, single lab\",\n      \"pmids\": [\"12242244\", \"12242245\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"SCF (KITLG) synergizes with G-CSF to promote expansion of primitive hematopoietic cells and peripheral blood progenitor cell mobilization. This synergy involves downregulation of p27Kip1 and independent phosphorylation of STAT3 on both tyrosine and serine residues as key intracellular biochemical events.\",\n      \"method\": \"MO7e-G cell system recapitulating SCF/G-CSF synergy, Western blot for p27Kip1, STAT3 phosphorylation (tyrosine and serine) analysis\",\n      \"journal\": \"Leukemia & lymphoma\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — mechanistic findings reported in a review/summary paper with limited methodological detail; single cell system\",\n      \"pmids\": [\"12152985\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Intracellular trafficking of KITLG (Kit ligand) to the cell surface is controlled at the level of the endoplasmic reticulum (ER) by a C-terminal valine residue in the cytoplasmic tail, positioned 19–36 amino acids from the transmembrane/cytoplasmic domain border. This valine functions as a specific ER export signal mediating recruitment of KITLG into COPII-coated ER exit sites and ER-to-Golgi vesicular transport. Deletion or substitution of this valine causes ER accumulation and reduced cell surface transport.\",\n      \"method\": \"Deletion/substitution mutagenesis of Kitl cytoplasmic tail, GFP-VSV-G fusion construct live imaging, COPII colocalization, cell surface biotinylation/transport assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis combined with live cell imaging and COPII colocalization; multiple orthogonal methods in single study establishing specific ER export signal\",\n      \"pmids\": [\"15475566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"KITLG (SCF) binding to c-Kit induces rapid and complete receptor dimerization, leading to activation by autophosphorylation of the catalytic tyrosine kinase domain. This generates signal transduction regulating cell growth through multiple pathways including PI3K, Src, JAK/STAT, PLC-γ, and MAPK. Gain-of-function mutations in the inhibitory juxtamembrane domain (exon 11) of c-Kit constitutively activate signaling independent of KITLG.\",\n      \"method\": \"Review integrating biochemical assays of c-Kit dimerization, autophosphorylation, and downstream pathway activation; mutational analysis of juxtamembrane domain\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — review article summarizing prior experimental findings without primary new data; well-established mechanism but not directly experimentally established in this paper\",\n      \"pmids\": [\"17659849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Tumor-derived KITLG (SCF) mediates mast cell chemotactic migration (at low concentrations) and activation (at higher concentrations) via c-Kit receptor on mast cells. Activated mast cells upregulate NF-κB and AP-1 activity in tumor cells, increase IL-17 expression, release adenosine, and expand T regulatory cells, thereby promoting immunosuppression. This establishes KITLG as the initiating signal for tumor microenvironment remodeling by mast cells.\",\n      \"method\": \"In vitro mast cell chemotaxis assays with recombinant SCF, cytokine measurement, NF-κB/AP-1 reporter assays, T cell suppression assays, flow cytometry\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional assays with defined ligand concentrations, single lab, several orthogonal readouts\",\n      \"pmids\": [\"18524989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"KITLG (KIT ligand/KITL) attenuates 4-vinylcyclohexene diepoxide (VCD)-induced primordial and primary follicle loss in rat ovaries. VCD decreases Kit expression and increases Kitl mRNA and protein, suggesting compensatory upregulation. Addition of exogenous KITL to ovarian cultures during VCD exposure rescues follicle loss, establishing that KIT/KITL signaling is critical for follicular survival.\",\n      \"method\": \"In vivo VCD dosing and in vitro ovarian culture, microarray analysis, qPCR, Western blot, growth factor rescue experiments in primary ovarian cultures\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — rescue experiment with defined ligand, in vivo and in vitro concordant results, single lab\",\n      \"pmids\": [\"18448842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SCF (KITLG) inhibits IGF-I-mediated proliferation in isolated growth plate chondrocytes by attenuating ERK1/2 activation, and promotes chondrocyte differentiation in ATDC5 cells. KITLG signals through its receptor KIT to modulate the pace of differentiation at the growth plate.\",\n      \"method\": \"Chondrocyte isolation and culture, proliferation assays, ERK1/2 phosphorylation Western blot, ATDC5 differentiation assay with collagen X/II/aggrecan markers\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct functional assay with recombinant ligand, defined signaling readout (ERK1/2), multiple cell systems\",\n      \"pmids\": [\"19897599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Mutations in KITLG cause familial progressive hyper- and hypopigmentation (FPHH). Three missense mutations (including p.Val33Ala and p.Thr34Pro) located in a conserved β-strand of KITLG co-segregate with disease, suggesting this structural region is important for activation of the c-Kit receptor. The same gene harbors mutations causing familial progressive hyperpigmentation (FPH) and likely DUH2, establishing KITLG as an important modulator of skin pigmentation.\",\n      \"method\": \"Genome-wide linkage analysis, mutation screening, co-segregation analysis in seven families\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — genetic co-segregation without direct functional validation of mutation mechanism in this paper\",\n      \"pmids\": [\"21368769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Mutations in KITLG cause non-syndromic unilateral/asymmetric hearing loss and Waardenburg syndrome type 2. In vitro studies showed that the p.His67_Cys68delinsArg transmembrane isoform of KITLG is not detectable at the cell membrane, supporting loss-of-function pathogenicity. The p.Leu104Val mutation associated with WS2 produces a transmembrane KITLG that localizes to the cell membrane but yields reduced secreted soluble KITLG, suggesting a dominant-negative or gain-of-function effect via impaired shedding.\",\n      \"method\": \"Cell surface localization assay (immunofluorescence/flow cytometry), ELISA for soluble KITLG in conditioned medium, transfection of mutant constructs\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct in vitro functional studies of mutant protein localization and secretion, multiple isoforms tested, single lab\",\n      \"pmids\": [\"26522471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HIF-1α directly binds to the hypoxia response element (HRE) region of the KITLG promoter under hypoxic conditions, activating KITLG transcription in pancreatic ductal adenocarcinoma cells. KITLG knockdown under hypoxia reduces cell proliferation and invasion, and exogenous SCF (KITLG) rescues these defects after HIF-1α knockdown, placing KITLG downstream of HIF-1α in promoting PDAC progression.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) assay, luciferase reporter assay, RNAi knockdown, Western blot, colony formation and Transwell invasion assays, in vivo xenograft with digoxin (HIF-1α inhibitor)\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — ChIP and luciferase assay establish direct transcriptional regulation; functional rescue supports pathway placement; single lab\",\n      \"pmids\": [\"25799412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"KITL (Kit ligand) supports retinoic acid-induced spermatogonial differentiation in a soma-free culture system. KITL activates an alternative pathway downstream of retinoic acid that is distinct from NRG1/ERBB2/ERBB3 signaling — ERBB2 inhibitors do not block KITL-dependent spermatogonial development, and KITL prevents degeneration of ERBB3-deficient spermatogonia upon differentiation.\",\n      \"method\": \"Soma-free spermatogonial culture with defined factors, ERBB2 inhibitor treatment, ERBB3-deficient cells, retinoic acid treatment, morphological and marker assessment of differentiation\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic (ERBB3-deficient) and pharmacological (ERBB2 inhibitor) dissection of pathway; soma-free system isolates germline-intrinsic signaling\",\n      \"pmids\": [\"26500786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MAPK3/1 (ERK1/2) participates in primordial follicle activation through a mTORC1-KITL signaling axis in pre-granulosa cells. MAPK3/1 inhibition with U0126 reduces follicle activation, decreases phosphorylation of Tsc2, S6K1, and rpS6, and reduces KITL expression. The reduction in KITL leads to decreased Akt phosphorylation in oocytes and impaired Foxo3 nuclear export, linking MAPK3/1 upstream of mTORC1-KITL signaling.\",\n      \"method\": \"Ex vivo neonatal ovary culture with U0126 (MAPK3/1 inhibitor) and bpV(HOpic) (PTEN inhibitor), Western blot, immunofluorescence, follicle counting\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibition with multiple downstream readouts establishing pathway order; single lab, two experimental models\",\n      \"pmids\": [\"28218391\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SCF (KITLG)/cKIT signaling induces pathological ocular neovascularization mechanistically through phosphorylation of glycogen synthase kinase-3β (GSK-3β), enhancement of β-catenin nuclear translocation, and transcription of β-catenin target genes related to angiogenesis. Hypoxia upregulates cKIT expression in endothelial cells, enhancing their angiogenic response to SCF. In vivo, anti-SCF neutralizing IgG and cKit mutant mice show substantially suppressed pathological ocular neovascularization.\",\n      \"method\": \"cKit mutant mice, anti-SCF neutralizing antibody, β-catenin chemical inhibitors, Western blot for GSK-3β phosphorylation and β-catenin, oxygen-induced retinopathy and laser-induced CNV models, β-catenin agonist rescue experiment\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic and pharmacological loss-of-function with defined biochemical mechanism (GSK-3β/β-catenin), in vitro and in vivo concordant results, rescue experiment\",\n      \"pmids\": [\"31434494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Gαi1 and Gαi3 associate with SCF (KITLG)-activated c-Kit in endothelial cells, promote c-Kit endocytosis and binding of key adaptor proteins, and are required for downstream SCF/c-Kit signal transduction. SCF-induced Akt-mTOR and ERK activation is robustly attenuated by Gαi1/3 silencing or dominant-negative mutations, and SCF-induced HUVEC proliferation, migration, and capillary tube formation are suppressed. In vivo endothelial knockdown of Gαi1/3 reduces SCF-induced retinal angiogenesis.\",\n      \"method\": \"Co-immunoprecipitation of Gαi1/3 with c-Kit, Gαi1/3 siRNA/KO/dominant-negative/overexpression, Akt and ERK phosphorylation Western blots, HUVEC functional assays, intravitreous AAV-shRNA injection in mice, streptozotocin diabetic retinopathy model\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP establishing physical interaction, multiple loss/gain-of-function approaches with defined signaling and functional readouts, in vitro and in vivo concordance\",\n      \"pmids\": [\"37063428\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Cadmium (Cd) exposure alters the kitl1/kitl2 mRNA ratio through changes in alternative splicing of kitl pre-mRNA in murine ovarian granulosa cells, associated with altered expression of 29 miRNAs. miRNAs including mmu-miR-27a-3p, mmu-miR-34b-5p, mmu-miR-297a-3p, mmu-miR-129-5p, and mmu-miR-107-3p show expression changes consistent with a regulatory role in kitl alternative splicing.\",\n      \"method\": \"In vitro granulosa cell Cd exposure, isoform-specific RT-PCR, miRNA microarray, bioinformatics pathway analysis, qPCR validation of miRNAs\",\n      \"journal\": \"Journal of applied toxicology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — associative miRNA-splicing correlation without direct functional validation of miRNA effects on splicing; single lab\",\n      \"pmids\": [\"28892167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"miR-27a directly targets the 3'UTR of KITLG mRNA, negatively regulating KITLG mRNA and protein expression. Overexpression of miR-27a in HEK-293T cells reduces KITLG expression, and dual-luciferase reporter assays confirm direct miR-27a binding to the KITLG 3'UTR. In goat skin, miR-27a expression is higher in white vs. brown animals and inversely correlates with KITLG expression.\",\n      \"method\": \"Luciferase 3'UTR reporter assay, miR-27a overexpression in HEK-293T cells, Western blot and qRT-PCR in goat skin, in vivo/in vitro concordance\",\n      \"journal\": \"Animal biotechnology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct 3'UTR luciferase validation confirms miR-27a targets KITLG; in vivo correlation supports finding; single lab\",\n      \"pmids\": [\"31613171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"miR-34c directly targets KITLG mRNA, and resveratrol upregulates miR-34c to suppress KITLG expression in colorectal cancer cells. Lentiviral knockdown of miR-34c rescues KITLG and partially reverses the anti-cancer effects of resveratrol, while miR-34c overexpression reduces KITLG. The anti-CRC effect of resveratrol is partially mediated through the miR-34c-KITLG axis, confirmed in xenograft models.\",\n      \"method\": \"Lentiviral miR-34c overexpression/inhibitor, Western blot and qPCR for KITLG, xenograft mouse model, methylation-specific PCR for miR-34c promoter\",\n      \"journal\": \"BMC cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss/gain-of-function of miR-34c with KITLG readout, in vitro and in vivo concordance, single lab\",\n      \"pmids\": [\"26674205\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KITLG (Kit ligand/stem cell factor) is a dimeric growth factor produced in both membrane-bound and soluble isoforms whose cell surface transport is governed by a C-terminal valine ER export signal that recruits KITLG into COPII-coated vesicles; upon binding the c-Kit receptor tyrosine kinase, KITLG induces receptor dimerization and autophosphorylation, activating downstream cascades including PI3K/Akt, ERK/MAPK, JAK/STAT, and PLC-γ, with Gαi1/3 proteins serving as required intermediaries for c-Kit endocytosis and signal transduction; in hematopoietic and reproductive tissues, KITLG acts through the adaptor Gab2 to activate ERK and Akt for mast cell development, drives spermatogonial DNA synthesis and differentiation through KIT signaling downstream of FSH/cAMP in Sertoli cells and retinoic acid in the germline, regulates primordial follicle activation through a MAPK3/1→mTORC1→KITL→KIT/PI3K axis in granulosa and oocyte compartments, controls melanocyte migration and survival through spatiotemporally specific ligand expression, and promotes ocular neovascularization via GSK-3β phosphorylation and β-catenin nuclear translocation; KITLG expression is transcriptionally activated by HIF-1α binding to its promoter HRE under hypoxia, and post-transcriptionally repressed by miR-34c and miR-27a targeting its 3'UTR, while loss-of-function mutations in conserved helical or β-strand domains cause pigmentation disorders, hearing loss, and Waardenburg syndrome.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"KITLG (Kit ligand/Steel factor/SCF) is a dimeric growth factor that signals through the c-Kit receptor tyrosine kinase to control survival, proliferation, migration, and differentiation across hematopoietic, reproductive, pigmentary, and vascular lineages [#1, #8]. Ligand binding induces c-Kit dimerization and autophosphorylation, engaging downstream PI3K/Akt, MAPK/ERK, JAK/STAT, Src, and PLC-\\u03b3 cascades [#8]; in mast cells these outputs require the adaptor Gab2, whose loss impairs KITLG-induced ERK and Akt activation and markedly reduces mast cell numbers in vivo [#3], while G\\u03b1i1/G\\u03b1i3 associate with activated c-Kit to drive receptor endocytosis and are required for SCF-induced Akt-mTOR and ERK signaling in endothelial cells [#18]. KITLG exists as membrane-bound and soluble isoforms with distinct activities, and its delivery to the cell surface depends on a C-terminal valine ER export signal that recruits it into COPII-coated ER exit sites [#7, #2]. KITLG governs lineage-specific developmental programs: it drives FSH/cAMP-stimulated DNA synthesis and retinoic-acid-coupled differentiation in the spermatogonial lineage [#0, #15], supports ovarian follicle survival and primordial follicle activation downstream of a MAPK3/1\\u2192mTORC1\\u2192KITL axis [#10, #16], and controls spatiotemporal melanocyte migration and survival [#4]. In disease contexts, KITLG transcription is activated by HIF-1\\u03b1 binding to a promoter hypoxia response element to promote pancreatic tumor progression [#14], and SCF/c-Kit signaling drives pathological ocular neovascularization through GSK-3\\u03b2 phosphorylation and \\u03b2-catenin nuclear translocation [#17]; KITLG message is post-transcriptionally repressed by miR-27a and miR-34c via its 3'UTR [#20, #21]. Loss-of-function or trafficking-defective KITLG mutations cause pigmentation disorders, hearing loss, and Waardenburg syndrome type 2 [#13].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Established that the KITLG/c-Kit axis is the essential, non-redundant determinant of a defined cell lineage in vivo, anchoring KITLG as a developmental growth factor rather than a modulatory one.\",\n      \"evidence\": \"Genetic W/Wv c-Kit loss-of-function mice with mast cell reconstitution across tissues\",\n      \"pmids\": [\"1280935\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not resolve which downstream signaling branches mediate each mast cell behavior\", \"Phenotype assessed via receptor loss, not direct ligand manipulation\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Defined how KITLG expression is hormonally controlled and showed soluble ligand alone drives a specific proliferative response, establishing a tissue context (testis) for KITLG action.\",\n      \"evidence\": \"Sertoli cell culture with FSH/cAMP, isoform-specific PCR, and [3H]-thymidine incorporation in type A spermatogonia\",\n      \"pmids\": [\"7677988\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream c-Kit signaling pathway in spermatogonia not dissected\", \"Relative roles of soluble vs membrane isoform in vivo unresolved\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Demonstrated functional non-equivalence of the membrane-bound and soluble KITLG isoforms, showing that membrane presentation can be required to sustain c-Kit-dependent proliferation.\",\n      \"evidence\": \"FDC-P1/c-Kit fibroblast co-culture using Sl/Sld mutant fibroblasts producing only soluble SLF\",\n      \"pmids\": [\"7684700\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis for differential isoform activity not defined\", \"Mechanism of GM-CSF/IL-3-induced c-Kit downregulation unexplained\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showed that spatiotemporally restricted KITLG expression patterns the migration and survival of a developing lineage, distinguishing c-Kit-dependent from c-Kit-independent stages.\",\n      \"evidence\": \"SCF transgenic mice, anti-c-Kit antibody blockade, and Sl/W mutant analysis of melanocyte development\",\n      \"pmids\": [\"11764276\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular signaling controlling each developmental stage not mapped\", \"Source cells of KITLG at each stage not fully defined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Placed an intracellular adaptor (Gab2) downstream of c-Kit, identifying a required node converting receptor activation into the ERK and Akt outputs needed for mast cell development.\",\n      \"evidence\": \"Gab2 knockout mice and bone marrow-derived mast cell culture with phospho-ERK/Akt readouts\",\n      \"pmids\": [\"11861309\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Gab2 is recruited to c-Kit not defined\", \"Whether Gab2 dependence generalizes to other KITLG-responsive lineages unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Linked KITLG to cooperative cytokine signaling and specific cell-cycle/transcriptional effectors in primitive hematopoietic cell expansion.\",\n      \"evidence\": \"MO7e-G synergy system with p27Kip1 and STAT3 phosphorylation Westerns (review/summary paper)\",\n      \"pmids\": [\"12152985\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Reported in a summary paper with limited methodological detail\", \"Direct causal link between STAT3/p27 changes and expansion not demonstrated\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Mapped functional KITLG residues onto conserved alpha-helical domains, providing the first structure-function correlation for the ligand.\",\n      \"evidence\": \"ENU mutagenesis allelic series at the Steel locus with phenotype-severity correlation\",\n      \"pmids\": [\"12242244\", \"12242245\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Biochemical effect of each missense mutation on c-Kit binding not measured\", \"No high-resolution structure to interpret residue roles\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified the molecular determinant controlling KITLG surface delivery, showing a C-terminal valine acts as an ER export signal recruiting KITLG into COPII vesicles.\",\n      \"evidence\": \"Cytoplasmic-tail deletion/substitution mutagenesis with COPII colocalization and surface biotinylation/transport assays\",\n      \"pmids\": [\"15475566\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"COPII coat component that reads the valine signal not identified\", \"Whether trafficking is regulated to tune surface ligand levels unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Consolidated the receptor-proximal mechanism: KITLG drives c-Kit dimerization and autophosphorylation feeding into multiple defined signaling pathways.\",\n      \"evidence\": \"Review integrating c-Kit dimerization, autophosphorylation, and downstream pathway and juxtamembrane mutation analyses\",\n      \"pmids\": [\"17659849\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No primary new data in this paper\", \"Pathway selection across cell types not addressed\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Extended KITLG function into the tumor microenvironment, showing concentration-dependent control of mast cell chemotaxis versus activation and downstream immunosuppression.\",\n      \"evidence\": \"In vitro mast cell chemotaxis/activation assays, NF-\\u03baB/AP-1 reporters, and Treg suppression assays with recombinant SCF\",\n      \"pmids\": [\"18524989\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance of the concentration thresholds not established\", \"Whether soluble or membrane KITLG drives this in tumors unclear\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrated that KITLG supplementation rescues follicle loss, establishing KIT/KITL signaling as a survival factor for ovarian primordial and primary follicles.\",\n      \"evidence\": \"In vivo VCD dosing plus in vitro ovarian culture with exogenous KITL rescue, microarray, qPCR, Western blot\",\n      \"pmids\": [\"18448842\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signaling pathway mediating follicle survival not dissected here\", \"Mechanism of compensatory Kitl upregulation unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed KITLG can act as a brake on proliferation and a driver of differentiation in a non-hematopoietic tissue, attenuating IGF-I/ERK signaling in chondrocytes.\",\n      \"evidence\": \"Growth plate chondrocyte and ATDC5 cultures with proliferation, ERK1/2 phospho-Westerns, and differentiation markers\",\n      \"pmids\": [\"19897599\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which KITLG attenuates IGF-I-driven ERK not defined\", \"In vivo skeletal relevance not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identified KITLG mutations in a conserved beta-strand as a cause of human progressive pigmentation disorders, translating ligand structure-function to human disease.\",\n      \"evidence\": \"Genome-wide linkage and mutation co-segregation analysis across seven families with FPHH\",\n      \"pmids\": [\"21368769\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No functional validation of mutation effect on c-Kit activation in this study\", \"Mechanism (gain vs loss of function) not resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Established KITLG as a Mendelian deafness/Waardenburg gene and linked specific mutations to defective surface localization or impaired soluble ligand shedding, distinguishing loss-of-function from dominant-negative mechanisms.\",\n      \"evidence\": \"Transfection of mutant constructs with surface localization assays and ELISA for soluble KITLG\",\n      \"pmids\": [\"26522471\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Shedding machinery affected by the WS2 mutation not identified\", \"In vivo confirmation of dominant-negative mechanism lacking\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Showed KITLG operates as an alternative, ERBB-independent effector pathway for retinoic-acid-induced spermatogonial differentiation, refining its germline role.\",\n      \"evidence\": \"Soma-free spermatogonial culture with ERBB2 inhibitor and ERBB3-deficient cells under retinoic acid\",\n      \"pmids\": [\"26500786\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Intracellular signaling distinguishing KITL from NRG1/ERBB pathways not mapped\", \"Source of KITL in soma-free system unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined direct transcriptional control of KITLG by HIF-1\\u03b1, placing the ligand downstream of hypoxia signaling to promote tumor progression.\",\n      \"evidence\": \"ChIP and luciferase reporter on the KITLG promoter HRE, RNAi, and SCF rescue after HIF-1\\u03b1 knockdown in PDAC with xenografts\",\n      \"pmids\": [\"25799412\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether tumor cell-autonomous or paracrine c-Kit signaling mediates the effect not resolved\", \"Single cancer context\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified miR-34c as a direct 3'UTR repressor of KITLG, embedding the ligand in a resveratrol-responsive anti-cancer regulatory axis.\",\n      \"evidence\": \"Luciferase 3'UTR assay, lentiviral miR-34c gain/loss-of-function with KITLG readout, colorectal xenografts\",\n      \"pmids\": [\"26674205\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological contexts where miR-34c sets KITLG levels not defined\", \"Other 3'UTR regulators not surveyed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Ordered MAPK3/1 upstream of an mTORC1-KITL axis in primordial follicle activation, linking somatic ERK signaling to oocyte Akt/Foxo3 control via the ligand.\",\n      \"evidence\": \"Neonatal ovary culture with U0126 and PTEN inhibitor, Western blots of Tsc2/S6K1/rpS6/Akt, and follicle counting\",\n      \"pmids\": [\"28218391\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcriptional mechanism by which mTORC1 controls KITL not shown\", \"In vivo genetic confirmation lacking\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Associated environmental cadmium with altered kitl isoform ratios via splicing and a candidate miRNA program, implicating post-transcriptional control of KITLG isoforms.\",\n      \"evidence\": \"Granulosa cell Cd exposure with isoform-specific RT-PCR and miRNA microarray\",\n      \"pmids\": [\"28892167\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Associative miRNA-splicing correlation without functional validation\", \"No demonstration that named miRNAs control kitl splicing directly\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined a discrete biochemical mechanism for KITLG-driven pathological angiogenesis through GSK-3\\u03b2 phosphorylation and \\u03b2-catenin nuclear translocation, validated genetically and pharmacologically in vivo.\",\n      \"evidence\": \"cKit mutant mice, anti-SCF antibody, \\u03b2-catenin inhibitors/agonist rescue, GSK-3\\u03b2/\\u03b2-catenin Westerns, OIR and laser-CNV models\",\n      \"pmids\": [\"31434494\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How c-Kit activation links to GSK-3\\u03b2 phosphorylation mechanistically not detailed\", \"Relative contribution of canonical PI3K/MAPK branches not separated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Confirmed miR-27a as a direct 3'UTR repressor of KITLG that inversely correlates with KITLG in pigmented tissue, reinforcing post-transcriptional control of ligand levels.\",\n      \"evidence\": \"Luciferase 3'UTR assay, miR-27a overexpression in HEK-293T, and Western/qRT-PCR in goat skin\",\n      \"pmids\": [\"31613171\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence for pigmentation not directly tested\", \"Whether miR-27a regulation operates in human tissue unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified G\\u03b1i1/G\\u03b1i3 as physical partners of activated c-Kit required for receptor endocytosis and propagation of SCF-induced Akt-mTOR and ERK signaling, revealing a heterotrimeric G-protein requirement in this RTK pathway.\",\n      \"evidence\": \"Reciprocal Co-IP of G\\u03b1i1/3 with c-Kit, siRNA/KO/dominant-negative perturbation, phospho-Westerns, HUVEC assays, and AAV-shRNA in retinal angiogenesis models\",\n      \"pmids\": [\"37063428\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How G\\u03b1i proteins are recruited to c-Kit not defined\", \"Whether this requirement extends beyond endothelial cells unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How distinct KITLG-c-Kit signaling outputs (PI3K/Akt vs ERK vs JAK/STAT) are selected to produce lineage-specific outcomes across hematopoietic, germline, melanocyte, and vascular contexts remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking isoform choice and adaptor usage to pathway selection\", \"No structural model of the human KITLG-c-Kit complex in the corpus\", \"Tissue-specific determinants of soluble vs membrane KITLG signaling undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [1, 8, 18]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 8, 18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 7, 13]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [7, 13]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 2, 13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 8, 17, 18]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 4, 10, 16]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [1, 3, 9]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [13, 14, 17]},\n      {\"term_id\": \"R-HSA-1474165\", \"supporting_discovery_ids\": [0, 10, 15, 16]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"KIT\", \"GAB2\", \"GNAI1\", \"GNAI3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}